HeartSciences Inc. Form 8-K Summary
Business Context and Reporting Period
HeartSciences Inc. (HSCS) filed this Current Report on Form 8-K on May 21, 2025, regarding the formal designation of a new class of preferred stock. The Company, incorporated in Texas, is an emerging growth company. This filing follows a previously disclosed Offering Statement filed in February 2025 and amended in March 2025.
Key Financial Metrics and Capital Structure
This filing does not report operational financial metrics such as revenue, profit, cash flow, or margins. The primary financial activity disclosed is a capital raise structure:
- Offering Size: Up to 4,285,714 Units for a maximum gross amount of $15,000,000.
- Offering Price: $3.50 per Unit.
- Unit Composition: One share of Series D Convertible Preferred Stock and one warrant to purchase one share of Common Stock.
- Warrant Exercise Price: $5.00 per share.
- Liquidation Preference: $3.50 per share of Series D Preferred Stock plus any declared but unpaid dividends.
Material Changes
On May 21, 2025, the Company submitted the Certificate of Designations to the Texas Secretary of State, officially designating 4,285,714 shares of preferred stock as "Series D Convertible Preferred Stock." This action enables the Company to proceed with the sale of Units as described in the Offering Statement.
Terms, Outlook, and Risks
Stock Terms: The Series D Preferred Stock is perpetual, non-maturing, and non-redeemable. It ranks senior to Common Stock regarding dividends and liquidation rights but carries no voting rights except as required by law. It does not bear a dividend unless declared by the Board.
Conversion Mechanics: Holders may convert shares into Common Stock at a 1:1 ratio. The Company may force conversion if: (i) a Change in Control occurs; (ii) the Common Stock trades at or above $5.00 for 10 consecutive trading days; or (iii) the Company completes a firm commitment underwritten public offering of at least $15 million at $5.00 or more per share.
Outlook: The filing indicates the Company is actively pursuing capital formation to support its operations, contingent on the successful completion of the offering.
Investor Verification Checklist
- Verify the final closing amount of the $15 million offering, as the filing only discloses the maximum potential raise.
- Confirm the official filing status of the Certificate of Designations with the Texas Secretary of State.
- Review the full text of Exhibit 4.1 (Certificate of Designation) for specific definitions of "Change in Control" and other legal nuances.
- Monitor the Common Stock price to assess the likelihood of the forced conversion trigger ($5.00 for 10 consecutive days).
- Check for the subsequent Form 8-K filing mentioned in the text, which will be submitted upon official approval of the Certificate of Designations.